| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/03/2011 | WO2011064254A1 Use of a vaccine against the vzv/hsv3 virus for treating hsv1 and/or hsv2 herpes virus infections |
| 06/03/2011 | WO2011063615A1 Macrocyclic amides, pharmaceutical compositions, preparation methods and uses thereof |
| 06/03/2011 | WO2011063553A1 Traditional chinese medicine for treating flu induced by flu virus including type a h1n1 virus |
| 06/03/2011 | WO2011063502A1 Hepatitis c inhibitor compounds |
| 06/03/2011 | WO2011063501A1 Hepatitis c inhibitor compounds |
| 06/03/2011 | WO2011042684A3 Antimicrobial composition and method of controlling contamination or infections using said composition |
| 06/03/2011 | WO2011042613A3 Antimicrobial composition |
| 06/03/2011 | WO2011033225A3 Substituted 3-amino-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof |
| 06/03/2011 | WO2011007230A3 Lupeol-type triterpene derivatives as antivirals |
| 06/03/2011 | WO2010147397A3 New lactic acid bacteria having inhibitory effect on avian influenza virus infections and composition containing same |
| 06/03/2011 | WO2010100381A9 Novel antiviral agent |
| 06/03/2011 | WO2010091197A3 Tablets for combination therapy |
| 06/03/2011 | WO2010049776A8 Drug for treating infections |
| 06/03/2011 | CA2782024A1 Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases |
| 06/03/2011 | CA2781746A1 Inhibition of pancreatic lipase |
| 06/03/2011 | CA2781645A1 Compositions, methods and uses for expression of enterobacterium-associated peptides |
| 06/03/2011 | CA2780033A1 Sialochimeric compounds |
| 06/03/2011 | CA2779404A1 Markers associated with ribavirin-induced anemia |
| 06/03/2011 | CA2776471A1 Surfactant-free, water-free, foamable compositions and breakable foams and their uses |
| 06/03/2011 | CA2687013A1 Method and composition for treatment and prevention of broad spectrum virus ailments |
| 06/02/2011 | US20110130707 Thiadiazole Compounds and Uses Thereof |
| 06/02/2011 | US20110130705 Therapy for vitiligo |
| 06/02/2011 | US20110130704 Combination of a light ray and a lipase-bioconvertible compound for improving skin and/or hair appearance |
| 06/02/2011 | US20110130448 Functionalized phenolic esters and amides and polymers therefrom |
| 06/02/2011 | US20110130436 Caspase inhibitors and uses thereof |
| 06/02/2011 | US20110130433 Hepatitis C Virus Inhibitors |
| 06/02/2011 | US20110130415 Protein kinase c inhibitors and uses thereof |
| 06/02/2011 | US20110130414 Novel fused thiazolo and oxazolo pyrimidinones |
| 06/02/2011 | US20110130412 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 06/02/2011 | US20110130409 Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders |
| 06/02/2011 | US20110130397 Pyrrolinone compounds as inhibitors of bacterial peptidyl trna hydrolase and uses thereof |
| 06/02/2011 | US20110130396 Imidazothiadiazole derivatives |
| 06/02/2011 | US20110130395 P13k isoform selective inhibitors |
| 06/02/2011 | US20110130391 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 06/02/2011 | US20110130380 Heteroaryl Kinase Inhibitors |
| 06/02/2011 | US20110130378 Ezetimibe process and composition |
| 06/02/2011 | US20110130357 Aminoglycosides: Synthesis and Use as Antifungals |
| 06/02/2011 | US20110130354 Sulfated oligosaccharide derivatives |
| 06/02/2011 | US20110130353 Highly purified antiendotoxin compound |
| 06/02/2011 | US20110130349 Compounds and Methods for Treating Toll-Like Receptor 2-Related Diseases and Conditions |
| 06/02/2011 | US20110130331 Modified growth hormones |
| 06/02/2011 | US20110130328 Flavivirus fusion inhibitors |
| 06/02/2011 | US20110130327 Multi-Arm Amines and Uses Thereof |
| 06/02/2011 | US20110130326 Defensins for treatment of infective endocarditis |
| 06/02/2011 | US20110129883 Inactivation of genes of the mep pathway |
| 06/02/2011 | US20110129547 Preparation for care and protection of skin with children and adults, method for obtaining thereof |
| 06/02/2011 | US20110129546 Dermatological pharmaceutical composition for the treatment of skin inflammation diseases, such as dermatitis, atopic dermatitis, vitiligo, alopecia areata, acne, psoriasis, pruritus or combinations of same |
| 06/02/2011 | US20110129543 Fermented plant extracts, methods of production and uses |
| 06/02/2011 | US20110129539 Oral pharmaceutical formulation in the form of an aqueous suspension of microcapsules for modified release of amoxicillin |
| 06/02/2011 | US20110129536 Nanocomposite materials based on metallic nanoparticles stabilized with branched polysaccharides |
| 06/02/2011 | US20110129532 Method and means for treating viral disease, in particular hiv/aids |
| 06/02/2011 | US20110129530 Compressible-Coated Pharmaceutical Compositions and Tablets and Methods of Manufacture |
| 06/02/2011 | US20110129529 Probiotic products for pet applications |
| 06/02/2011 | US20110129516 Ocular drug delivery devices |
| 06/02/2011 | US20110129513 Compositions and methods for coating medical implants |
| 06/02/2011 | US20110129512 Antimicrobial Releasing Polymers |
| 06/02/2011 | US20110129502 Immunogenic Constructs |
| 06/02/2011 | US20110129501 Vaccine comprising recombinant clpp protein of streptococcus pneumoniae |
| 06/02/2011 | US20110129500 Lawsonia intracellularis bacterium of a novel serotype, vaccine based on that bacterium, antibodies suitable for diagnosing the novel lawsonia intracellularis serotype and hybridomas for producing the said antibodies |
| 06/02/2011 | US20110129499 Dual delivery system for heterologous antigens |
| 06/02/2011 | US20110129498 Vaccine for the prevention and therapy of hcv infections |
| 06/02/2011 | US20110129497 Methods for designing and preparing vaccines comprising directed sequence polymer compositions via the directed expansion of epitopes |
| 06/02/2011 | US20110129496 Use of mTOR Inhibitors to Enhance T Cell Immune Responses |
| 06/02/2011 | US20110129495 Treatment of prdc in pigs |
| 06/02/2011 | US20110129493 Combined measles-human papilloma vacine |
| 06/02/2011 | US20110129492 Immunostimulatory Recombinant Intracellular Pathogen Immunogenic Compositions and Methods of Use |
| 06/02/2011 | US20110129490 Modulation of production of retroviruses by apobec4 |
| 06/02/2011 | US20110129489 Methods for generating an immune response using dna and a viral vector |
| 06/02/2011 | US20110129479 Immunogen selection directed in immunoglobulin packages in plasma and colostrum and method of making and using same |
| 06/02/2011 | US20110129475 Basb 205 polypeptides and polynucleotides from haemophilus influenzae |
| 06/02/2011 | US20110129474 Methods And Systems For Multi-Antibody Therapies |
| 06/02/2011 | US20110129464 Humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodies |
| 06/02/2011 | US20110129460 Combination Antibodies For The Treatment And Prevention Of Disease Caused By Bacillus Anthracis And Related Bacteria And Their Toxins |
| 06/02/2011 | US20110129454 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
| 06/02/2011 | US20110129448 Methods to mobilize progenitor/stem cells |
| 06/02/2011 | US20110129444 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 06/02/2011 | US20110129443 Macrocyclic serine protease inhibitors |
| 06/02/2011 | US20110129440 Heterocyclic Urea and Thiourea Derivatives and Methods of Use Thereof |
| 06/02/2011 | US20110129438 Immunogenic protein constructs |
| 06/02/2011 | US20110129432 L-menthyl-n-(2-hydroxyphenyl)carbamate |
| 06/02/2011 | US20110129426 Oral compositions containing enhanced antibacterial combinations of antioxidants and extracts of magnolia |
| 06/02/2011 | US20110129421 Matrix metalloprotease targeting nucleic acids |
| 06/02/2011 | US20110126501 Composition for prevention of influenza viral infection comprising tannic acid, air filter comprising the same and air cleaning device comprising the filter |
| 06/01/2011 | EP2327789A1 Novel compound signamycin, method for production thereof, and use thereof |
| 06/01/2011 | EP2327717A1 Replikin peptides and uses thereof |
| 06/01/2011 | EP2327716A1 Replikin peptides and uses thereof |
| 06/01/2011 | EP2327715A1 Replikin peptides and uses thereof |
| 06/01/2011 | EP2327714A1 Prophylactic or therapeutic agent for influenza virus infection |
| 06/01/2011 | EP2327687A2 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 06/01/2011 | EP2327686A2 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 06/01/2011 | EP2327423A2 Human antibodies against human interleukin-22 (IL-22) |
| 06/01/2011 | EP2327419A1 Microneedle device, and method for enhancing the efficacy of influenza vaccine by using microneedle devive |
| 06/01/2011 | EP2327418A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from other viruses |
| 06/01/2011 | EP2327410A1 Avermectins and milbemycins for the treatment of flavivirus infections |
| 06/01/2011 | EP2327409A1 Tetracycline compound having target therapeutic activities |
| 06/01/2011 | EP2326671A1 Lps based vaccines |
| 06/01/2011 | EP2326668A1 Anti-il-12/il-23 antibodies |
| 06/01/2011 | EP2326661A1 Synthetic peptides corresponding to overlapping neutralizing determinants in the cbd1 epitope induce broadly neutralizing antibodies. |
| 06/01/2011 | EP2326640A1 Pyrrole carboxylic acid derivatives as antibacterial agents |
| 06/01/2011 | EP2326633A1 Compounds for the treatment of hepatitis c |